20/20 Biolabs, Inc. Reports Results for Quarter Ended June 30, 2026

What Happened
On August 17, 2026, 20/20 Biolabs, Inc. announced and furnished a press release reporting its financial results for the quarter ended June 30, 2026. The press release is attached to the Form 8-K as Exhibit 99.1.

Key Details

• Filing date: August 17, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period covered: quarter ended June 30, 2026.
• Exhibit included: Exhibit 99.1 (press release). The filing also includes the Cover Page Interactive Data File (Inline XBRL) as Exhibit 104.
• The 8-K furnishes the press release; the detailed financial figures and commentary are contained in Exhibit 99.1.

Why It Matters
This 8-K signals that 20/20 Biolabs has released its latest quarterly results (earnings/revenue/quarterly results) — information investors typically use to assess recent performance and update valuations or expectations. The Form 8-K points readers to the press release for the specific financial figures and management commentary; investors should review Exhibit 99.1 and the company’s periodic filings for complete financial details and any forward-looking statements.